Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
49.10
+2.30 (4.91%)
Jun 12, 2025, 2:45 PM CST
9.77%
Market Cap 21.90B
Revenue (ttm) 2.42B
Net Income (ttm) 101.52M
Shares Out 445.34M
EPS (ttm) 0.21
PE Ratio 232.52
Forward PE 40.98
Dividend n/a
Ex-Dividend Date n/a
Volume 6,355,246
Average Volume 5,108,786
Open 46.80
Previous Close 46.80
Day's Range 46.52 - 49.10
52-Week Range 31.07 - 49.52
Beta 0.62
RSI 75.85
Earnings Date Aug 22, 2025

About Sinocelltech Group

Sinocelltech Group Limited, a biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China. The company offers Anpingxi an antibody drug and anti-tumor product; Anjiayin for the treatment of the rare disease hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and mutant strain recombinant protein vaccines SCTV01C and SCTV01E. Its pipeline products include SCT630 used for the treatment of autoimmune diseases; SCT510 for the treatment of ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,277
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.